NuVasive, Inc. (OQ:NUVA)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: 7475 Lusk Blvd
SAN DIEGO CA 92121-5707
Tel: 1-858-4582240
Website: https://www.nuvasive.com
IR: See website
<
Key People
Gregory T. Lucier
Chairman of the Board
J. Christopher Barry
Chief Executive Officer, Director
Matthew K. Harbaugh
Executive Vice President, Chief Financial Officer
Lucas Vitale
Chief Human Resource Officer
Brent J. Boucher
Executive Vice President - Global Commercial
Massimo Calafiore
Executive Vice President - Global Business Units
Nathaniel B. Sisitsky
Senior Vice President, General Counsel, Corporate Secretary
Dale A. Wolf
Senior Vice President - Global Operations
 
Business Overview
Nuvasive, Inc. is a medical device company. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine surgery. Its product portfolio focuses on applications for spine fusion surgery, including biologics used to aid in the spinal fusion process. Its principal product offering includes a minimally-disruptive surgical platform called Maximum Access Surgery (MAS). The platform includes its software-driven nerve detection and avoidance systems, including NVM5, and intraoperative monitoring services and support; MaXcess, an integrated split-blade retractor system, and a range of implants and biologics. The platform combines three product categories: its MaXcess retractors, specialized implants and fixation products, and nerve monitoring systems and service offerings that collectively enable surgeons to detect and navigate around nerves, while directing customized access to the spine for implant delivery.
Financial Overview
For the nine months ended 30 September 2020,NuVasive, Inc. revenues decreased 12% to $758.8M. Net losstotaled $38.8M vs. income of $35.4M. Revenues reflectSpinal Hardware segment decrease of 10% to $564.6M,Surgical Support segment decrease of 17% to $194.2M, UnitedStates segment decrease of 14% to $597.6M, International(excludes Puerto Rico) segment decrease of 2% to $161.2M.Net loss reflects Other (expense) income.
Employees: 2,800 as of Dec 31, 2019
Reporting Currency: U.S. Dollars
Enterprise value: $2,867M as of Sep 30, 2020
Annual revenue (TTM): $1,069M as of Sep 30, 2020
EBITDA (TTM): $197.09M as of Sep 30, 2020
Net annual income (TTM): -$8.97M as of Sep 30, 2020
Free cash flow (TTM): $77.78M as of Sep 30, 2020
Net Debt Last Fiscal Year: $426.12M as of Sep 30, 2020
Shares outstanding: 51,283,615 as of Oct 27, 2020
Index Membership: S&P 400 Mid Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.